ATE161848T1 - Glycyrrheticsäurederivate - Google Patents

Glycyrrheticsäurederivate

Info

Publication number
ATE161848T1
ATE161848T1 AT92104149T AT92104149T ATE161848T1 AT E161848 T1 ATE161848 T1 AT E161848T1 AT 92104149 T AT92104149 T AT 92104149T AT 92104149 T AT92104149 T AT 92104149T AT E161848 T1 ATE161848 T1 AT E161848T1
Authority
AT
Austria
Prior art keywords
glycyrrhetic acid
acid derivatives
salt
antiinflammatory
antioxidant
Prior art date
Application number
AT92104149T
Other languages
German (de)
English (en)
Inventor
Kazumi Ogata
Kyouzo Yamamoto
Reiko Matsuda
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Application granted granted Critical
Publication of ATE161848T1 publication Critical patent/ATE161848T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT92104149T 1991-03-13 1992-03-11 Glycyrrheticsäurederivate ATE161848T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3128799A JP2998287B2 (ja) 1991-03-13 1991-03-13 グリチルレチン酸誘導体

Publications (1)

Publication Number Publication Date
ATE161848T1 true ATE161848T1 (de) 1998-01-15

Family

ID=14993725

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92104149T ATE161848T1 (de) 1991-03-13 1992-03-11 Glycyrrheticsäurederivate

Country Status (10)

Country Link
US (1) US5229378A (enExample)
EP (1) EP0503582B1 (enExample)
JP (1) JP2998287B2 (enExample)
KR (1) KR0185717B1 (enExample)
AT (1) ATE161848T1 (enExample)
CA (1) CA2062652A1 (enExample)
DE (1) DE69223827T2 (enExample)
ES (1) ES2112870T3 (enExample)
RU (1) RU2065864C1 (enExample)
TW (1) TW201750B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254321B (it) * 1992-04-10 1995-09-14 Kemiprogress S R L Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale.
US5519008A (en) * 1992-09-10 1996-05-21 Glycomed Incorporated Derivatives of triterpenoid acids as inhibitors of cell-adhesion molecules ELAM-1 (E-selectin) and LECAM-1 (L-selectin)
US5527890A (en) * 1993-04-16 1996-06-18 Glycomed Incorporated Derivatives of triterpenoid acids and uses thereof
CN1034334C (zh) * 1993-08-14 1997-03-26 贵州省中医研究所 齐酞酸钠及其药物组合物
US5922335A (en) * 1995-05-15 1999-07-13 Avon Products, Inc. Uses for ascorbyl-phosphoryl-cholesterol in topical compositions
US5866147A (en) * 1995-05-15 1999-02-02 Avon Products, Inc. Ascorbyl-phosphoryl-cholesterol
US6162450A (en) * 1995-05-15 2000-12-19 Avon Products, Inc. Uses of ascorbyl-phosphoryl-cholesterol and compositions for practicing same
US5951990A (en) * 1995-05-15 1999-09-14 Avon Products, Inc. Ascorbyl-phosphoryl-cholesterol
US5607968A (en) * 1995-06-07 1997-03-04 Avon Products, Inc. Topical alkyl-2-O-L-ascorbyl-phosphates
CA2195185C (en) * 1996-05-14 2003-07-22 Dmitri Ptchelintsev Ascorbyl-phosphoryl-cholesterol
US6303321B1 (en) 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
US7151082B2 (en) * 1999-02-11 2006-12-19 The Feinstein Institute For Medical Research Antagonists of HMG1 for treating inflammatory conditions
CN1496271B (zh) 2001-02-16 2010-04-28 阿斯比奥制药株式会社 伴随有aop-1基因或aop-1的表达减少的疾病的治疗方法以及该疾病的治疗药
US7304034B2 (en) * 2001-05-15 2007-12-04 The Feinstein Institute For Medical Research Use of HMGB fragments as anti-inflammatory agents
US7696169B2 (en) * 2003-06-06 2010-04-13 The Feinstein Institute For Medical Research Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
CA2538763C (en) * 2003-09-11 2015-05-05 Critical Therapeutics, Inc. Monoclonal antibodies against hmgb1
WO2007084253A2 (en) * 2005-11-28 2007-07-26 Medimmune, Inc. High affinity antibodies against hmgb1 and methods of use thereof
EP1909834A2 (en) * 2005-07-18 2008-04-16 Critical Therapeutics, Inc. Use of hmgb1 antagonists for the treatment of inflammatory skin conditions
RU2623876C2 (ru) * 2014-11-10 2017-06-29 Александр Владимирович Диковский Фармацевтическая композиция для лечения гиперлипидемии
RU2611362C1 (ru) * 2015-11-26 2017-02-21 Федеральное государственное бюджетное учреждение науки Институт химической биологии и фундаментальной медицины Сибирского отделения Российской академии наук (ИХБФМ СО РАН) Водорастворимая композиция, обладающая противоопухолевой активностью и способ ее получения
CN115813859B (zh) * 2022-12-13 2024-05-17 五邑大学 一种甘草次酸配体脂质体及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL24113A (en) * 1965-08-08 1969-06-25 Greidinger D Glycyrrhetic acid phosphoric acid ester and salts thereof
GB1093908A (en) * 1965-11-26 1967-12-06 Biorex Laboratories Ltd New derivatives of glycyrrhetinic acid
GB1229562A (enExample) * 1969-01-17 1971-04-28
US3734944A (en) * 1970-05-15 1973-05-22 Biorex Laboratories Ltd Glycyrrhetinic acid esters
GB1476053A (en) * 1975-02-07 1977-06-10 Biorex Laboratories Ltd Glycyrrhetinic acid derivatives
IL89850A0 (en) * 1988-04-25 1989-12-15 Takeda Chemical Industries Ltd Ester of ascorbic acid 2-phosphate

Also Published As

Publication number Publication date
JP2998287B2 (ja) 2000-01-11
EP0503582B1 (en) 1998-01-07
DE69223827T2 (de) 1998-06-18
DE69223827D1 (de) 1998-02-12
US5229378A (en) 1993-07-20
KR920018062A (ko) 1992-10-21
TW201750B (enExample) 1993-03-11
RU2065864C1 (ru) 1996-08-27
ES2112870T3 (es) 1998-04-16
KR0185717B1 (ko) 1999-05-15
EP0503582A1 (en) 1992-09-16
JPH04330088A (ja) 1992-11-18
CA2062652A1 (en) 1992-09-14

Similar Documents

Publication Publication Date Title
ATE161848T1 (de) Glycyrrheticsäurederivate
PL343419A1 (en) Benzofurylpyrone derivatives
EP1004573A4 (en) ARYLOXYANILINE DERIVATIVES
AU3381389A (en) Derivative of caffeic acid and pharmaceutical composition containing the same
GR3020682T3 (en) Use of dioxabicyclo [3.3.0]octane derivatives for the manufacture of a medicament for inhibiting the metabolism of cholesterol.
EP0408044A3 (en) Anti-inflammatory and/or anti-allergic composition comprising glutathione derivatives
FI911016A0 (fi) Menetelmä farmakologisesti aktiivisten substituoitujen -diketonien valmistamiseksi
GB9510858D0 (en) Process for preparing lipoic acid
EP0719773A4 (en) IMIDAZOLIDINONE DERIVATIVES, THEIR ACID ADDITION SALTS AND THEREFORE AGENTS AGAINST SENILE DENTENCE
EP0385446A3 (en) Osteogenesis promotion with use of vitamin d derivatives
NZ216110A (en) 4-(z)-6-((2,4,5-cis -2-alkyl-4-(2-hydroxyphenyl)-1,3- dioxan-5-yl) hexenoic acid derivatives and pharmaceutical compositions
PH30229A (en) Pyridyl substituted benzothiazole compounds which has useful pharmaceutical utility
FR2499076B1 (enExample)
ATE125256T1 (de) Zwischenprodukte der mureidomycin-gruppe, ihre herstellung und verwendung.
AU2014188A (en) Naphthothiazepine derivatives and preparation thereof
ES510828A0 (es) "un procedimiento para la preparacion de un derivado de morfolina".
HUT53093A (en) Process for producing substituted 3-amino-sidnonimine derivatives and pharmaceutical compositions them as active components
HU908253D0 (en) New 1,2,3,6-tetrahydropyridine derivatives
DE69303847D1 (de) Indolderivate
TW353071B (en) Chromene compounds with neutroleptic activity, their preparation and pharmaceutical compositions
DE3879058D1 (de) 4-piperidincarboxamid-derivate.
HUT51895A (en) Process for production of antiflammation medical compositions containing derivatives of imidasole

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties